Pfizer stops clinical trials of cholestorol-controlling Tor


<p><a href="http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/afp/20061203/hl_afp/uscompanyhealthpfizer"><img src="http://d.yimg.com/us.yimg.com/p/afp/20061203/capt.sge.rte26.031206142844.photo00.photo.default-512x348.jpg?x=130&y=88&sig=DqYJIHhtIy4ylgtNOaGDEA--" align="left" height="88" width="130" alt="Pfizer headquarters in New York in January 2006. Citing the "interests of patient safety," US drug manufacturer Pfizer said it was stopping all clinical trials of the cholesterol-controlling drug Torcetrapib.(AFP/File/Timothy A. Clary)" border="0" /></a>AFP - Citing the "interests of patient safety," US drug manufacturer Pfizer said it was stopping all clinical trials of the cholesterol-controlling drug Torcetrapib.</p><br clear="all"/>